P59Q (p.Pro59Gln) variant of TAFAZZIN (Q16635)
P59Q (p.Pro59Gln) in TAFAZZIN (Q16635) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes population frequency data and structural context.
P59Q (p.Pro59Gln) variant details
- p.Pro59Gln
- rs1557191098
- NCI-TCGA Cosmic COSV9918
- cosmic curated COSV99185
- gnomAD rs1557191098
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.602
- CADD 23.60
- PolyPhen-2 0.95
- SIFT 0.19
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available